Fang Consulting can assist you with the FDA authorization process.
Fang Consulting can assist you with the FDA authorization process.
Fang Consulting can assist you with the FDA authorization process. Our expertise lies in medical device compliance, and our team of expert consultants has an in-depth understanding of the FDA submission process and how to avoid potential mistakes that could prolong your path to authorization. We can prepare and submit your 510(k) application more efficiently, with a reduced likelihood of receiving an initial “Refuse to Accept” (RTA) hold or an Additional Information (AI) request from the FDA reviewer. Quicker clearance from the FDA results in earlier sales for your device.
Fang Consulting can provide support to all stages of the 510(k) submission process, including:
A predicate is a legally marketed medical device that shares the same intended use and technological characteristics as the device being submitted and serves as a benchmark for demonstrating substantial equivalence. Identifying the correct predicate for your device is critical to the success of your 510(k) submission.
Classification review is based on factors such as the device’s intended use, technological characteristics, and potential risks to patients. Fang Consulting can assist in classifying your device based on the level of regulatory control necessary to ensure its safety and effectiveness, which determines the type of submission required for market clearance.
A medical device product code is a unique identifier the FDA assigns based on the device’s intended use and technological characteristics. It helps classify and track devices and is required in the submission. You must identify the correct product code when submitting a 510(k) to the FDA.
We can help identify any discrepancies between the requirements outlined by the FDA for the submission and the actual contents of the submission. By conducting a gap analysis, manufacturers can identify potential deficiencies or gaps in the submission and take corrective actions to improve their chances of obtaining clearance for their device.
Fang Consulting will review all performance data, including bench testing and clinical trials, and evaluate the safety and effectiveness to ensure the device meets regulatory standards and supports the claims made in the submission.
The FDA may come back with questions for the manufacturer intended to clarify aspects of the 510(k) submission. In this case, Fang Consulting will handle all back and forth with the FDA and promptly provide any additional requested information.
The submission process for a 510(k) typically involves a detailed description of the new or modified device, its intended use, and how it compares to the predicate device. The manufacturer must also provide information on any differences between the new device and the predicate device and demonstrate that these differences do not affect the safety or effectiveness of the new device.
The FDA then reviews the submission and determines whether the new device is substantially equivalent to the predicate device. If the FDA determines that the new device is substantially equivalent, it can be cleared for marketing in the US. If the FDA determines that the new device is not substantially equivalent, the manufacturer may need to submit additional information or data to support the safety and effectiveness of the device.
It is important to note that a 510(k) clearance does not mean that a device has been approved by the FDA. It simply means that the device has been cleared for marketing in the US based on its substantial equivalence to an existing device. The FDA can still take enforcement action against a device if safety or effectiveness concerns arise after it has been cleared for marketing.
Every year, the FDA receives around 3,000 submissions for new devices through the 510(k) process, but over 30% are rejected before they are even reviewed for failure to comply with the Refuse to Accept checklist. These rejections are usually due to poor-quality applications. The top 5 reasons the FDA rejects a submission are: using incorrect FDA templates, discrepancies in information, not following the RTA checklist, choosing the incorrect predicate device, and skipping not applicable sections. Preparing a comprehensive and well-organized 510(k) submission can significantly increase the likelihood of obtaining FDA clearance in the first round.
The FDA has established a 90-day review period for most 510(k) submissions, which means that the agency will typically issue a decision within 90 days of receiving the submission. However, this timeframe can be extended if the FDA determines that additional information is needed or if the submission is incomplete.
It is important to note that the 90-day review period only applies to the FDA’s review of the submission. The overall time it takes to complete the 510(k) submission process can be much longer, as manufacturers may need to address any deficiencies identified by the FDA and submit additional information or testing data.
Therefore, the overall timeline for the 510(k) submission process can vary widely, but it can typically take several months to a year or more to complete, depending on the complexity of the device and the completeness of the submission.
Fang Consulting has extensive experience in preparing and submitting 510(k) pre-market notifications for medical devices. In addition to this, Fang Consulting can also assist with the regulatory assessment of deciding when to submit a 510(k) for a change to an existing device or for a software change to an existing device. Our team of experts is well-versed in the complexities of the 510(k) process and has successfully assisted numerous clients in obtaining FDA clearance for their medical devices. Please give us a call at (612) 230-9909 or reach us at our website at www.FangConsulting.com to get started today.
Premarket Notification 510(k). (2022, 10 03). Retrieved from U.S. Food & Drug Administration: https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k#who
Zhang, X., Xu, Y., Feng, L., & Raciti, E. (2020). The Interplay Between the FDA Regulatory Process for Medical Devices and Patent Law – FDA Premarket Review of Medical Devices. Finnegan.
Fang Consulting can assist you with the FDA authorization process. Our expertise lies in medical device compliance, and our team of expert consultants has an in-depth understanding of the FDA submission process and how to avoid potential mistakes that could prolong your path to authorization. We can prepare and submit your 510(k) application more efficiently, with a reduced likelihood of receiving an initial “Refuse to Accept” (RTA) hold or an Additional Information (AI) request from the FDA reviewer. Quicker clearance from the FDA results in earlier sales for your device.
Fang Consulting can provide support to all stages of the 510(k) submission process, including:
Identifying a predicate
A predicate is a legally marketed medical device that shares the same intended use and technological characteristics as the device being submitted and serves as a benchmark for demonstrating substantial equivalence. Identifying the correct predicate for your device is critical to the success of your 510(k) submission.
Medical device classification review
Classification review is based on factors such as the device’s intended use, technological characteristics, and potential risks to patients. Fang Consulting can assist in classifying your device based on the level of regulatory control necessary to ensure its safety and effectiveness, which determines the type of submission required for market clearance.
Medical device product code review
A medical device product code is a unique identifier the FDA assigns based on the device’s intended use and technological characteristics. It helps classify and track devices and is required in the submission. You must identify the correct product code when submitting a 510(k) to the FDA.
Preparing a detailed gap analysis
We can help identify any discrepancies between the requirements outlined by the FDA for the submission and the actual contents of the submission. By conducting a gap analysis, manufacturers can identify potential deficiencies or gaps in the submission and take corrective actions to improve their chances of obtaining clearance for their device.
Performance data reviewal
Fang Consulting will review all performance data, including bench testing and clinical trials, and evaluate the safety and effectiveness to ensure the device meets regulatory standards and supports the claims made in the submission.
Answering post-submission questions from the FDA
The FDA may come back with questions for the manufacturer intended to clarify aspects of the 510(k) submission. In this case, Fang Consulting will handle all back and forth with the FDA and promptly provide any additional requested information.